The firm upgraded Palantir from Underperform to Market Perform after a sharp stock decline but did not assign a price target.

Palantir (PLTR) was upgraded to Market Perform from Underperform by William Blair, following the recent share price decline ...

Investment analysts at William Blair decreased their Q2 2025 earnings estimates for HEICO in a research note issued to ...

Investment analysts at William Blair reduced their Q4 2025 earnings per share estimates for Powerfleet in a report released ...

Fintel reports that on March 5, 2025, William Blair upgraded their outlook for Palantir Technologies (NasdaqGS:PLTR) from ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ: PLTR) to Market Perform following a 33% selloff from ...

If you are looking for an AI stock that is more promising than PLTR but that trades at less than 5 times its earnings, check ...

William Blair upgraded Palantir (PLTR) to Market Perform from Underperform without a price target The firm cites valuation for the upgrade ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

Going into 2025, the PGM remains strong, with the potential for other regions to start closing the gap with the United States ...

“DeepSeek adheres to an open-source approach and promotes the widespread application of AI technology globally, which ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...